Ülker Aydemir

INC Research/inVentiv Health

Articles

Estimands and Implications for Sponsors as ICH E9 (R1) Addendum Progresses

December 13, 2017

Sponsors should be aware of the significant implications the Addendum is likely to have on clinical trial planning, conduct, statistical analysis, and interpretation.